XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday.
美國股票走勢不一，道瓊斯指數週一下跌超過100點。
Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Monday's session.
小鵬汽車股份有限公司（紐交所：XPEV）的股價在週一交易中大幅上漲。
The company delivered 30,895 vehicles last month, marking an increase of 54% year-over-year and 29% from October.
該公司上個月交付了30,895輛車，同比增長54%，比十月份增長了29%。
The Guangzhou-based EV startup said that the company's deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.
總部位於廣州的電動汽車初創企業表示，該公司小鵬Mona M03掀背轎跑車的交付量自推出以來連續三個月超過1萬輛。公司上個月推出的小鵬P7+轎車的交付量也超過7,000輛。
XPeng shares jumped 6.4% to $12.82 on Monday.
小鵬汽車股價週一上漲6.4%，至12.82美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易中漲幅較大的其他大股票。
- NovoCure Limited (NASDAQ:NVCR) shares gained 29.9% to $26.04 after the company announced its Phase 3 PANOVA-Trial met its primary endpoint and demonstrated a statistically significant improvement in its median overall survival rate.
- Super Micro Computer, Inc. (NASDAQ:SMCI) surged 22% to $39.83 after the company announced it completed a review by an independent special committee and stated EY's conclusions were not supported by findings.
- Fastly, Inc. (NYSE:FSLY) jumped 17% to $9.92.
- Nebius Group N.V. (NASDAQ:NBIS) shares gained 15.5% to $25.40 after the company announced it entered a $700 million private placement financing agreement with institutional investors.
- Enovix Corporation (NASDAQ:ENVX) gained 15.1% to $10.65.
- Zeta Global Holdings Corp. (NYSE:ZETA) jumped 14.6% to $24.41.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) surged 14.3% to $50.15 after the company announced it signed a global licensee and collaboration agreement with Novartis for its PTC518 Huntington's Disease program.
- Dana Incorporated (NYSE:DAN) gained 14% to $11.39 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $18.
- MINISO Group Holding Limited (NYSE:MNSO) gained 12.9% to $22.60. The company, on Friday, posted first-quarter results.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) climbed 11.3% to $7.87.
- Akso Health Group (NASDAQ:AHG) rose 8.8% to $0.9000.
- Abercrombie & Fitch Co. (NYSE:ANF) gained 8.2% to $161.94.
- Merus N.V. (NASDAQ:MRUS) gained 8% to $48.43 after the company announced it entered into an agreement to exclusively license the right to Ptx the right to commercialize Zenocutuzumab (Zeno) for Nrg1 Fusion-positive cancer in the US.
- The Gap, Inc. (NYSE:GAP) rose 5.7% to $25.63 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $28 to $30.
- 諾華醫療有限公司（納斯達克：NVCR）股價上漲29.9%，至26.04美元，因公司宣佈其第三階段PANOVA試驗達到了主要終點，並且在中位數總體生存率上表現出顯著統計學改善。
- 超微計算機有限公司（納斯達克：SMCI）股價飆升22%，至39.83美元，該公司宣佈已完成獨立特別委員會的審查，並表示安永所得出的結論不被調查結果支持。
- Fastly公司(NYSE:FSLY)股價上漲17%，達9.92美元。
- Nebius Group N.V. (NASDAQ:NBIS)股票上漲15.5%，至25.40美元，該公司宣佈與機構投資者達成了70000萬美元的私募融資協議。
- Enovix Corporation (NASDAQ:ENVX)股價上漲15.1%，至10.65美元。
- Zeta Global Holdings Corp. (紐約證券交易所:ZETA)股價上漲14.6%，至24.41美元。
- PTC Therapeutics, Inc. (納斯達克:PTCT)股價大漲14.3%，至50.15美元，該公司宣佈與Novartis全球達成了PTC518亨廷頓病項目的許可和合作協議。
- Dana Incorporated (紐約證券交易所:DAN)股價上漲14%，至11.39美元，巴克萊將股票評級從等權重升級爲超重，並將價格目標從12美元提高到18美元。
- 名創優品控股有限公司(NYSE:MNSO)股價上漲12.9%，至22.60美元。該公司在週五發佈了第一季度業績報告。
- Recursion Pharmaceuticals, Inc. (納斯達克:RXRX)股價上漲11.3%，至7.87美元。
- Akso Health集團（納斯達克：AHG）上漲8.8%，至0.9000美元。
- Abercrombie＆Fitch公司（紐交所：ANF）漲幅8.2%，至161.94美元。
- Merus N.V.（納斯達克：MRUS）漲幅8%，至48.43美元，該公司宣佈已達成獨家許可協議，獨家授權Ptx商業化Zenocutuzumab（Zeno）用於美國的Nrg1融合陽性癌症。
- Gap公司（紐交所：GAP）上漲5.7%，至25.63美元，摩根大通將其股票評級從中立調升至超重，並將其價格目標從28美元上調至30美元。
Now Read This:
現在閱讀這個:
- Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師對3只高股息收益的金融股票發表看法。
譯文內容由第三人軟體翻譯。
